搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
1 天
Rhythm Pharmaceuticals: A Key Year Ahead
Discover the latest on Rhythm Pharmaceuticals, Inc. and its asset, imcivree, targeting rare obesity disorders and potential ...
PipelineReview.com
2 天
Denali Therapeutics Announces First Participant Dosed in Phase 2a Study of LRRK2 Inhibitor ...
SOUTH SAN FRANCISCO, CA, USA I 05, 2024 I Denali Therapeutics Inc. (Nasdaq: DNLI) today announced initiation of dosing in a global Phase 2a clinical ...
manilatimes
10 天
Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib ...
Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
GlobalData on MSN
12 天
Alector stock drops after Alzheimer’s drug fails in Phase II trial
The therapy failed to slow disease progression in patients with early Alzheimer’s in the INVOKE-2 trial (NCT04592874).
BMJ
17 天
Acral and periorificial scaly erythematous plaques in a child
Zinc supplementation was started. Genetic testing done simultaneously showed compound heterozygous mutations in SLC39A4 in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈